Open access
Aug 2026
Relationship between initial dose, dose intensity, and survival in unresectable pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid
Reduced starting dose and RDI <80% were not associated with inferior survival, suggesting that individualized dose modification may be feasible, and future prospective studies are warranted to refine NFF dosing strategies.
Y. Ueda, Hiroki Taguchi, Mototsugu Shimokawa et al.
· Scientific Reports · 0 citations